$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long is the resistance to lorlatinib/lorlatinib (Borina) generally?
2026-02-01 22:25:32
Check Details
Can I buy Cabozantinib in Hong Kong and how much does it cost?
2026-02-01 22:25:32
Check Details
Who is the manufacturer of Bosutinib?
2026-02-01 22:25:32
Check Details
What is the cost of a month of Nintedanib?
2026-02-01 22:25:32
Check Details
Instructions for subcutaneous injection of evantuzumab (Rybrevant Faspro) in Chinese
2026-02-01 22:25:32
Check Details
What are the indications of Upatinib/Reif and what patients should pay attention to
2026-02-01 22:25:32
Check Details
Are there any generic versions of bimetinib/bemetinib?
2026-02-01 22:25:32
Check Details
Comprehensive analysis of the main effects of Teritusumab/Telivac
2026-02-01 22:25:32
Check Details
Quizartinib latest market price reference in 2026
2026-02-01 22:25:32
Check Details
DREAMM-8 study triplet (pomalidomide/mablantumumab/dexamethasone) maintains PFS, MRD negativity in R/R multiple myeloma
2026-02-01 22:25:32
Check Details
The role and efficacy of subcutaneous injection of evantuzumab (Rybrevant Faspro)
2026-02-01 22:25:32
Check Details
How long does the effect of Selumetinib/Coselyu generally last?
2026-02-01 22:25:32
Check Details
1
2
...
2400
2401
2402
2403
2404
2405
2406
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
2
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
3
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
4
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
5
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
9
Adagrasib Medication Management Guide for Special Populations
10
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
11
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
12
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment